Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Gains from Investment Securities: 2010-2025

Historic Gains from Investment Securities for Argan (AGX) over the last 10 years, with Oct 2025 value amounting to $19.3 million.

  • Argan's Gains from Investment Securities rose 222.67% to $19.3 million in Q4 2025 from the same period last year, while for Oct 2025 it was $51.5 million, marking a year-over-year increase of 129.68%. This contributed to the annual value of $583,337 for FY2025, which is 57.26% down from last year.
  • Latest data reveals that Argan reported Gains from Investment Securities of $19.3 million as of Q4 2025, which was up 199.44% from $6.5 million recorded in Q3 2025.
  • Argan's Gains from Investment Securities' 5-year high stood at $19.7 million during Q1 2025, with a 5-year trough of -$17,000 in Q3 2022.
  • For the 3-year period, Argan's Gains from Investment Securities averaged around $6.7 million, with its median value being $5.8 million (2023).
  • Per our database at Business Quant, Argan's Gains from Investment Securities slumped by 102.93% in 2022 and then soared by 15,217.65% in 2023.
  • Argan's Gains from Investment Securities (Quarterly) stood at $580,000 in 2021, then slumped by 102.93% to $943,000 in 2022, then spiked by 297.88% to $3.8 million in 2023, then surged by 59.78% to $6.0 million in 2024, then surged by 222.67% to $19.3 million in 2025.
  • Its Gains from Investment Securities stands at $19.3 million for Q4 2025, versus $6.5 million for Q3 2025 and $44,669 for Q2 2025.